ChartRow logo
TEVA
Teva Pharmaceutical Industries Limited American Depositary SharesStock · Health Care
$38.98-0.54%
as of market close, Sep 18, 2026
☾ AH
PeersMRNALLYUNHJNJMRKTMO

TEVA financial statements

The full income statement, balance sheet, and cash-flow statement for Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 1.13B2024-09 1.13B2024-12 1.13B2025-03 1.15B2025-06 1.15B2025-09 1.15B2025-12 1.15B2026-03 1.16B2026-06 1.17B+2.9% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue17.3B+4.3%16.5B+4.4%15.8B+6.2%14.9B-6.0%15.9B-4.7%
8.94B+10.8%8.06B+5.5%7.64B+9.6%6.97B-8.2%7.59B-1.7%
Cost of revenue8.32B-1.9%8.48B+3.4%8.20B+3.1%7.95B-4.0%8.28B-7.3%
Research & development1.01B+1.5%998M+4.7%953M+872.4%98.0M-89.9%967M-3.0%
Selling, general & administrative1.29B+10.9%1.16B-0.1%1.16B-1.5%1.18B+7.4%1.10B-6.3%
General & administrative1.29B+10.9%1.16B-0.1%1.16B-1.5%1.18B+7.4%1.10B-6.3%
Selling & marketing2.69B+5.7%2.54B+8.8%2.34B+3.1%2.27B-6.8%2.43B-2.8%
Restructuring225M+204.1%74.0M-33.3%111M-24.0%146M+9.8%133M+10.8%
Amortization of intangibles581M-1.2%588M-4.5%616M-15.8%732M-8.7%802M-21.4%
Operating income2.16B+811.9%-303M-170.0%433M+119.7%-2.20B-228.0%1.72B+148.0%
Interest expense916M-8.6%1.00B-2.6%1.03B+10.6%930M+4.4%891M-1.1%
Other non-operating income-934M+4.8%-981M+7.2%-1.06B-9.4%-966M+8.7%-1.06B-26.9%
Equity-method income15.0M+1400.0%1.00M-50.0%2.00M-90.5%21.0M+133.3%9.00M-93.5%
Pre-tax income1.22B+195.2%-1.28B-105.8%-624M+80.3%-3.16B-580.7%658M+114.9%
Income tax-180M-126.6%676M+9757.1%-7.00M+98.9%-643M-404.7%211M+225.6%
1.41B+186.0%-1.64B-193.2%-559M+77.1%-2.45B-686.6%417M+110.5%
Net income to non-controlling interest7.00M+102.2%-320M-471.4%-56.0M-5.7%-53.0M-235.9%39.0M+135.8%
$1.21+183.4%-$1.45-190.0%-$0.50+77.3%-$2.20-678.9%$0.38+110.4%
EPS (basic)$1.23+184.8%-$1.45-190.0%-$0.50+77.3%-$2.20-678.9%$0.38+110.4%
Weighted-avg shares (basic)1.15B+1.2%1.13B+1.1%1.12B+0.8%1.11B+0.7%1.10B+0.6%
Weighted-avg shares (diluted)1.16B+2.8%1.13B+1.1%1.12B+0.8%1.11B+0.3%1.11B+1.1%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
13.9B+11.1%12.6B+0.5%12.5B+3.6%12.1B-4.2%12.6B-3.3%
Cash & equivalents3.56B+7.8%3.30B+2.3%3.23B+15.2%2.80B+29.4%2.17B-0.6%
Accounts receivable3.71B+21.2%3.06B-10.2%3.41B-7.8%3.70B-18.4%4.53B-1.1%
Inventory3.18B+5.7%3.01B-25.2%4.02B+4.9%3.83B+0.4%3.82B-13.3%
Prepaid expenses1.12B+11.5%1.01B-19.8%1.25B+8.0%1.16B+8.1%1.07B+13.8%
Other current assets539M+31.8%409M-18.8%504M-8.2%549M-43.1%965M+35.9%
40.7B+3.6%39.3B-9.6%43.5B-1.2%44.0B-7.7%47.7B-5.9%
Property, plant & equipment4.08B-10.9%4.58B-20.3%5.75B+0.2%5.74B-4.1%5.98B-5.0%
Operating lease right-of-use345M-6.0%367M-7.6%397M-5.3%419M-15.4%495M-11.4%
Goodwill16.0B+0.0%16.0B-6.9%17.2B+0.0%17.2B-2.6%17.6B-14.5%
Intangible assets3.78B-14.4%4.42B-18.0%5.39B-14.1%6.27B-16.0%7.47B-16.3%
Deferred tax assets2.19B+21.8%1.80B-0.7%1.81B+24.3%1.46B+144.6%596M-14.2%
Other non-current assets405M-12.3%462M-1.7%470M+6.6%441M-14.4%515M-4.3%
13.5B+5.2%12.8B+4.5%12.2B+6.8%11.5B+4.0%11.0B-16.2%
Accounts payable225M+42.4%158M+46.3%108M-94.3%1.89B+11.9%1.69B-4.0%
Accrued liabilities
23.0M
Short-term & current debt1.80B+2.3%1.76B+6.6%1.65B-20.9%2.09B+48.7%1.40B-47.5%
Current lease liability288M-2.7%296M-7.5%320M-8.3%349M-16.1%416M-13.2%
Other current liabilities1.18B+15.9%1.02B-2.3%1.04B+3.9%1.00B+11.3%903M-3.2%
32.8B-2.3%33.6B-4.9%35.4B-0.2%35.4B-2.8%36.4B-8.0%
Long-term debt16.9B-5.4%17.8B-10.4%19.9B-6.5%21.3B-8.0%23.1B-9.3%
Non-current lease liability288M-2.7%296M-7.5%320M-8.3%349M-16.1%416M-13.2%
Operating lease liability (total)382M-0.3%383M-8.2%417M-5.7%442M-15.8%525M-11.8%
Finance lease liability (total)43.0M+87.0%23.0M-28.1%32.0M+45.5%22.0M-12.0%25.0M+19.0%
Other non-current liabilities3.81B-5.5%4.03B+0.2%4.02B+1.9%3.94B+53.0%2.58B+15.1%
Total non-current liabilities19.4B-6.9%20.8B-9.9%23.1B-3.5%23.9B-5.7%25.4B-3.9%
7.91B+47.2%5.37B-28.4%7.51B-3.8%7.80B-24.1%10.3B+2.5%
Common stock58.0M+0.0%58.0M+1.8%57.0M+0.0%57.0M+0.0%57.0M+0.0%
Additional paid-in capital28.1B+1.3%27.8B-0.2%27.8B+0.4%27.7B+0.5%27.6B+0.4%
Retained earnings-13.8B+9.3%-15.2B-12.1%-13.5B-4.3%-13.0B-23.2%-10.5B+3.8%
Treasury stock4.13B+0.0%4.13B+0.0%4.13B+0.0%4.13B+0.0%4.13B+0.0%
Accumulated other comprehensive income-2.39B+24.0%-3.15B-16.7%-2.70B+5.0%-2.84B-5.8%-2.68B-11.8%
Non-controlling interest4.00M-42.9%7.00M-98.9%620M-21.9%794M-17.8%966M-6.7%
Total equity incl. non-controlling7.91B+47.1%5.38B-33.8%8.13B-5.5%8.60B-23.5%11.2B+1.7%
Total liabilities & equity40.7B+3.6%39.3B-9.6%43.5B-1.2%44.0B-7.7%47.7B-5.9%
Common shares issued1.26B+1.4%1.24B+1.1%1.23B+0.8%1.22B+0.7%1.21B+0.6%
Shares outstanding (cover)1.15B+1.4%1.13B+1.1%1.12B+0.9%1.11B+0.7%1.10B+0.6%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.65B+32.2%1.25B-8.8%1.37B-14.0%1.59B+99.2%798M-34.4%
Depreciation & amortization1.00B-5.4%1.06B-8.2%1.15B-11.9%1.31B-1.7%1.33B-14.6%
Intangible amortization581M-1.2%588M-4.5%616M-15.8%732M-8.7%802M-21.4%
Share-based compensation157M+27.6%123M+1.7%121M-2.4%124M+4.2%119M-7.8%
Deferred income taxes-418M-22.9%-340M+68.3%-1.07B-1718.6%-59.0M+83.1%
Change in inventory152M-8.4%166M+212.9%-147M+9.8%-163M-142.9%380M+826.8%
Other operating activities81.0M-85.5%560M+818.0%61.0M+167.0%-91.0M-668.8%16.0M-84.0%
737M-6.9%792M-18.2%968M+47.6%656M-56.9%1.52B+76.5%
Capital expenditure501M+0.6%498M-5.3%526M-4.0%548M-2.5%562M-2.8%
Free cash flow1.15B+53.3%749M-11.0%842M-19.2%1.04B+341.5%236M-63.0%
Acquisitions0.00-100.0%15.0M0.00-100.0%7.00M0.00
Sales/maturities of investments42.0M+5.0%40.0M0.00-100.0%4.00M-97.7%172M+1333.3%
Other investing activities-5.00M-150.0%-2.00M-140.0%5.00M0.00+100.0%-1.00M+91.7%
-2.15B-20.1%-1.79B+6.4%-1.91B-28.6%-1.49B+31.5%-2.17B-15.2%
Long-term debt issued2.30B0.00-100.0%2.45B0.00-100.0%4.97B
Long-term debt repaid4.11B+150.6%1.64B-60.5%4.15B+203.3%1.37B-79.4%6.65B+255.4%
Common stock issued0.000.000.000.000.00
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
Other financing activities41.0M+612.5%-8.00M+96.2%-212M-79.7%-118M-1866.7%-6.00M-20.0%
FX effect on cash21.0M+112.1%-174M-480.0%-30.0M+75.6%-123M+3.9%-128M-1700.0%
Net change in cash256M+245.9%74.0M-81.2%393M-38.2%636M+2928.6%21.0M-89.6%
Interest paid950M-5.4%1.00B-6.9%1.08B+13.7%948M+3.8%913M+7.9%
Income taxes paid471M+58.1%298M-45.1%543M+9.7%495M-30.2%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap35.9B+43.6%25.0B+113.5%11.7B+15.5%10.1B+14.6%8.84B-16.5%
P/E25.5×21.2×
P/S2.1×+37.7%1.5×+97.1%0.8×+14.5%0.7×+20.2%0.6×-12.4%
P/B4.5×-2.5%4.7×+175.4%1.7×+46.2%1.2×+34.4%0.9×-18.5%
P/FCF31.3×-6.3%33.4×+73.3%19.2×-2.3%19.7×-47.4%37.4×+125.8%
Earnings yield3.9%4.7%
FCF yield3.2%+6.7%3.0%-42.3%5.2%+2.4%5.1%+90.0%2.7%-55.7%
Source filing10-K10-K10-K10-K10-K

About this data

Source: TEVA’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TEVA filings on SEC EDGAR → Not investment advice.